Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Spindler, A.

Refine Results

Resource Type

Availability

Faculty

Collection

Author

Language

Search results

  • RSS Feed
(1 - 3 of 3)
Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes
Genovese, M.C.; Adelsberg, J. van; Fan, C.P.; Graham, N.M.H.; Hoogstraten, H. van; Parrino, J.; ... ; EXTEND Study Investigators 2018
Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes
Article / Letter to editor
open access
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Fleischmann, R.; Schiff, M.; Heijde, D. van der; Ramos-Remus, C.; Spindler, A.; Stanislav, M.; ... ; Takeuchi, T. 2017
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Article / Letter to editor
open access
Oskira-3: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To a Tumor Necrosis Factor-alpha Antagonist
Genovese, M.; Heijde, D. van der; Keystone, E.; Spindler, A.; Benhamou, C.L.; Kavanaugh, A.; ... ; Weinblatt, M. 2013
Oskira-3: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To a Tumor Necrosis Factor-alpha Antagonist
Article / Letter to editor
metadata only